A detailed history of Manufacturers Life Insurance Company, The transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 35,112 shares of CRBU stock, worth $58,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,112
Previous 36,489 3.77%
Holding current value
$58,637
Previous $59,000 15.25%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.56 - $2.73 $2,148 - $3,759
-1,377 Reduced 3.77%
35,112 $68,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $8,495 - $26,482
5,244 Added 16.78%
36,489 $59,000
Q1 2024

May 14, 2024

SELL
$4.82 - $8.26 $4,135 - $7,087
-858 Reduced 2.67%
31,245 $160,000
Q4 2023

Feb 13, 2024

BUY
$3.58 - $6.25 $14,803 - $25,843
4,135 Added 14.78%
32,103 $183,000
Q3 2023

Nov 15, 2023

BUY
$4.08 - $8.14 $13,488 - $26,910
3,306 Added 13.41%
27,968 $133,000
Q2 2023

Aug 11, 2023

BUY
$4.04 - $5.47 $10,435 - $14,129
2,583 Added 11.7%
24,662 $104,000
Q4 2022

Aug 11, 2023

BUY
$5.57 - $11.01 $601 - $1,189
108 Added 0.49%
22,079 $138,000
Q4 2022

Feb 13, 2023

BUY
$5.57 - $11.01 $601 - $1,189
108 Added 0.49%
22,079 $138,000
Q3 2022

Aug 11, 2023

SELL
$5.34 - $12.79 $3,956 - $9,477
-741 Reduced 3.26%
21,971 $231,000
Q3 2022

Nov 03, 2022

SELL
$5.34 - $12.79 $3,956 - $9,477
-741 Reduced 3.26%
21,971 $232,000
Q2 2022

Aug 11, 2023

BUY
$5.1 - $9.74 $11,031 - $21,067
2,163 Added 10.53%
22,712 $123,000
Q2 2022

Aug 15, 2022

BUY
$5.1 - $9.74 $11,031 - $21,067
2,163 Added 10.53%
22,712 $123,000
Q1 2022

Aug 11, 2023

SELL
$8.42 - $15.32 $12,882 - $23,439
-1,530 Reduced 6.93%
20,549 $188,000
Q1 2022

May 20, 2022

BUY
$8.42 - $15.32 $81,143 - $147,638
9,637 Added 88.32%
20,549 $189,000
Q4 2021

Feb 16, 2022

BUY
$14.59 - $23.26 $16,997 - $27,097
1,165 Added 11.95%
10,912 $165,000
Q3 2021

Nov 12, 2021

BUY
$15.75 - $30.29 $153,515 - $295,236
9,747 New
9,747 $233,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $102M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.